Skip to main content

Market Overview

50 Stocks Moving In Thursday's Mid-Day Session

Share:

Gainers

  • Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) shares gained 84% to $34.90. Black Diamond Therapeutics priced its 10.5 million share IPO at $19 per share.
  • Arcadia Biosciences, Inc (NASDAQ: RKDA) gained 27.7% to $6.19. Arcadia Biosciences disclosed that it has secured over $3 million in initial seed purchase commitments in 50 days post launch of its GoodHemp line.
  • Lianluo Smart Limited (NASDAQ: LLIT) jumped 25% to $2.40.
  • Cleveland BioLabs, Inc. (NASDAQ: CBLI) rose 24.7% to $2.78 after declining 20.07% on Wednesday.
  • NanoViricides, Inc. (NYSE: NNVC) shares rose 21.1% to $11.48 after climbing 12.86% on Wednesday.
  • Miragen Therapeutics Inc (NASDAQ: MGEN) shares climbed 19.8% to $2.0250 after the company announced positive data from its ongoing Phase 1 trial of cobomarsen in adult t-cell leukemia/lymphoma patients with residual disease.
  • Aethlon Medical, Inc. (NASDAQ: AEMD) gained 19% to $4.03.
  • Inovio Pharmaceuticals, Inc. (NASDAQ: INO) rose 15.5% to $4.7450 after the company announced it is collaborating with Beijing Advaccine Biotechnology to advance INO-4800 against the coronavirus in China.
  • Farfetch Ltd (NYSE: FTCH) shares climbed 13.2% to $12.83 after the company announced it raised $250 million from Tencent and Dragoneer to support continued growth.
  • Vivint Smart Home, Inc. (NYSE: VVNT) rose 12% to $19.36.
  • Stoke Therapeutics, Inc. (NASDAQ: STOK) gained 11.7% to $26.70.
  • Tesla, Inc. (NASDAQ: TSLA) rose 11.3% to $646.53 after the company reported stronger-than-expected Q4 results. The company also reported Q4 Model 3 deliveries were up 46% year-over-year.
  • Cimpress plc (NASDAQ: CMPR) gained 10% to $122.48 following Q2 results.
  • Allied Healthcare Products, Inc. (NASDAQ: AHPI) gained 9.3% to $2.7750.
  • Homology Medicines, Inc. (NASDAQ: FIXX) shares surged 8.6% to $16.64.
  • Alpha Pro Tech, Ltd. (NYSE: APT) gained 8.5% to $6.32.
  • Earthstone Energy, Inc. (NYSE: ESTE) surged 7.6% to $4.97 after the company issued operations update and 2020 forecast.
  • Vir Biotechnology, Inc. (NASDAQ: VIR) climbed 7.5% to $24.17.
  • ServiceNow, Inc. (NYSE: NOW) rose 7.4% to $336.01 after the company reported better-than-expected Q4 EPS and sales results.
  • Novus Therapeutics Inc (NASDAQ: NVUS) rose 6% to $0.6355 after gaining 7.14% on Wednesday.
  • Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) shares rose 5.7% to $1.2370 after Foresight disclosed that its affiliate Rail Vision is in advanced negotiations with leading European train operator for first commercial agreement valued at up to €6.5 million.
  • MYOS Corporation (NASDAQ: MYOS) rose 5.6% to $1.50 after announcing distribution partnership with Chewy.
  • Mondelez International, Inc. (NASDAQ: MDLZ) rose 5.3% to $57.42 after the company reported better-than-expected Q4 EPS and sales results.
  • Sunrun Inc (NASDAQ: RUN) rose 4.4% to $17.68 after it was announced the company will join the S&P Smallcap 600.
  •  

Check out these big penny stock gainers and losers

Losers

  • Sundial Growers Inc. (NASDAQ: SNDL) shares dipped 38.3% to $1.5920 after the company's 6-K showed that the CEO & COO is expected to resign.
  • Annovis Bio, Inc. (NYSE: ANVS) shares fell 25.5% to $7.14. Annovis Bio shares climbed 59.8% on Wednesday after the company priced its initial public offering of 2,000,000 shares at $6.00 per share.
  • Briggs & Stratton Corporation (NYSE: BGG) dipped 21% to $3.94 after the company reported downbeat Q2 results and announced plans to suspend dividend.
  • Intelsat S.A. (NYSE: I) dropped 19.4% to $3.0450 on continued weakness after Senators introduced a bill that seeks to limit satellite incentive payments.
  • BioPharmX Corporation (NYSE: BPMX) fell 15.9% to $ 0.4880. BioPharmX shares dropped 25.47% on Wednesday after the company and Timber Pharmaceuticals announced entry into a merger agreement.
  • Aspen Technology, Inc. (NASDAQ: AZPN) fell 15.3% to $118.90 after the company reported worse-than-expected Q2 EPS and sales results.
  • Eros International Plc (NYSE: EROS) dropped 15% to $2.8150 after China's National Health Commission confirmed 7,700 cases of coronavirus and 170 deaths. NOTE: The coronavirus outbreak has caused selloffs in global markets.
  • Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) shares fell 14% to $0.4006. Conatus Pharmaceuticals shares climbed 13.86% on Wednesday after the company and Histogen entered into a definitive merger agreement.
  • DBV Technologies S.A. (NASDAQ: DBVT) fell 13.2% to $9.84 after the company announced the launch of a proposed global offering of ordinary shares for $125 million worth of company's ADS.
  • Ekso Bionics Holdings Inc (NASDAQ: EKSO) fell 13% to $0.3659.
  • GSX Techedu Inc. (NYSE: GSX) dipped 12.4% to $32.62. Shares of several Chinese companies are trading lower after China's National Health Commission confirmed 7,700 cases of coronavirus and 170 deaths. The coronavirus outbreak has caused selloffs in global markets.
  • Applied Genetic Technologies Corporation (NASDAQ: AGTC) dropped 11.6% to $6.51.
  • NIC Inc. (NASDAQ: EGOV) dipped 11.4% to $19.81 following Q4 results.
  • Amtech Systems, Inc. (NASDAQ: ASYS) dropped 11.4% to $5.59.
  • Accuray Incorporated (NASDAQ: ARAY) tumbled 11.2% to $3.7950.
  • Nautilus, Inc. (NYSE: NLS) fell 10.3% to $3.1650.
  • IEC Electronics Corp. (NASDAQ: IEC) dropped 10.3% to $8.14.
  • Molecular Data Inc. (NASDAQ: MKD) shares dipped 10% to $3.68.
  • STAAR Surgical Company (NASDAQ: STAA) fell 9.9% to $33.17.
  • Kirby Corporation (NASDAQ: KEX) dropped 9.6% to $76.64 following Q4 results.
  • BioNTech SE (NASDAQ: BNTX) fell 9.4% to $28.80.
  • Resolute Forest Products Inc. (NYSE: RFP) dropped 9.4% to $3.4150 after reporting Q4 results.
  • Danaos Corporation (NYSE: DAC) shares declined 8.7% to $6.02.
  • Albireo Pharma, Inc. (NASDAQ: ALBO) fell 8.5% to $21.80. Albireo priced its 1.9 million share public offering of common stock at $21 per share.
  • Cree, Inc. (NASDAQ: CREE) fell 8.2% to $46.53 after the company reported worse-than-expected Q2 EPS results.
  • Facebook, Inc. (NASDAQ: FB) shares fell 6.5% to $208.88 despite the company reporting better-than-expected Q4 EPS and sales results. Pivotal Research downgraded Facebook from Buy to Hold and lowered the price target from $245 to $215.
 

Related Articles (AEMD + AGTC)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Intraday Update Markets Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com